Rockwell Income Tax Expense vs Operating Income Analysis

RMTI Stock  USD 1.64  0.01  0.61%   
Rockwell Medical financial indicator trend analysis is much more than just breaking down Rockwell Medical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Rockwell Medical is a good investment. Please check the relationship between Rockwell Medical Income Tax Expense and its Operating Income accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rockwell Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.

Income Tax Expense vs Operating Income

Income Tax Expense vs Operating Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Rockwell Medical Income Tax Expense account and Operating Income. At this time, the significance of the direction appears to have weak relationship.
The correlation between Rockwell Medical's Income Tax Expense and Operating Income is 0.33. Overlapping area represents the amount of variation of Income Tax Expense that can explain the historical movement of Operating Income in the same time period over historical financial statements of Rockwell Medical, assuming nothing else is changed. The correlation between historical values of Rockwell Medical's Income Tax Expense and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Income Tax Expense of Rockwell Medical are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Income Tax Expense i.e., Rockwell Medical's Income Tax Expense and Operating Income go up and down completely randomly.

Correlation Coefficient

0.33
Relationship DirectionPositive 
Relationship StrengthVery Weak

Income Tax Expense

Operating Income

Operating Income is the amount of profit realized from Rockwell Medical operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Rockwell Medical is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.
Most indicators from Rockwell Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Rockwell Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rockwell Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.As of now, Rockwell Medical's Selling General Administrative is increasing as compared to previous years. The Rockwell Medical's current Issuance Of Capital Stock is estimated to increase to about 18.1 M, while Enterprise Value Multiple is projected to decrease to (9.75).
 2021 2022 2023 2024 (projected)
Total Operating Expenses27.9M20.9M15.4M19.7M
Cost Of Revenue64.4M68.7M74.9M41.4M

Rockwell Medical fundamental ratios Correlations

0.11-0.11-0.210.91-0.08-0.73-0.32-0.170.8-0.090.020.940.180.030.660.2-0.060.49-0.140.980.550.54-0.040.53-0.05
0.110.320.36-0.230.640.37-0.65-0.130.170.45-0.03-0.020.280.41-0.040.340.660.750.560.020.31-0.430.73-0.440.35
-0.110.320.59-0.290.530.29-0.460.54-0.10.56-0.28-0.270.540.590.07-0.040.460.350.55-0.18-0.16-0.320.5-0.330.56
-0.210.360.59-0.520.280.34-0.250.73-0.160.14-0.22-0.30.190.07-0.110.310.240.570.27-0.270.03-0.220.23-0.240.07
0.91-0.23-0.29-0.52-0.25-0.82-0.08-0.30.72-0.180.020.90.1-0.030.61-0.02-0.240.09-0.270.930.390.61-0.230.61-0.09
-0.080.640.530.28-0.250.47-0.84-0.26-0.10.91-0.13-0.340.70.87-0.010.320.940.340.97-0.230.14-0.640.91-0.650.79
-0.730.370.290.34-0.820.47-0.170.04-0.850.460.15-0.850.210.31-0.20.130.39-0.020.5-0.79-0.17-0.570.38-0.570.33
-0.32-0.65-0.46-0.25-0.08-0.84-0.170.26-0.19-0.73-0.01-0.05-0.71-0.74-0.32-0.52-0.81-0.61-0.76-0.18-0.40.28-0.750.29-0.68
-0.17-0.130.540.73-0.3-0.260.040.26-0.11-0.21-0.23-0.120.0-0.2-0.05-0.11-0.310.21-0.22-0.13-0.250.17-0.230.16-0.19
0.80.17-0.1-0.160.72-0.1-0.85-0.19-0.11-0.2-0.230.86-0.06-0.070.130.03-0.010.41-0.190.820.290.30.040.29-0.12
-0.090.450.560.14-0.180.910.46-0.73-0.21-0.20.0-0.380.850.960.070.110.790.150.91-0.240.02-0.480.82-0.490.89
0.02-0.03-0.28-0.220.02-0.130.15-0.01-0.23-0.230.0-0.040.0-0.170.30.23-0.190.0-0.14-0.010.290.31-0.140.310.05
0.94-0.02-0.27-0.30.9-0.34-0.85-0.05-0.120.86-0.38-0.04-0.11-0.250.490.09-0.280.36-0.40.980.460.6-0.260.6-0.32
0.180.280.540.190.10.70.21-0.710.0-0.060.850.0-0.110.880.370.090.50.230.730.060.2-0.010.57-0.030.8
0.030.410.590.07-0.030.870.31-0.74-0.2-0.070.96-0.17-0.250.880.130.00.750.140.88-0.110.0-0.410.8-0.420.89
0.66-0.040.07-0.110.61-0.01-0.2-0.32-0.050.130.070.30.490.370.130.24-0.080.310.020.610.510.51-0.050.510.16
0.20.34-0.040.31-0.020.320.13-0.52-0.110.030.110.230.090.090.00.240.440.530.150.140.32-0.170.2-0.18-0.04
-0.060.660.460.24-0.240.940.39-0.81-0.31-0.010.79-0.19-0.280.50.75-0.080.440.350.85-0.19-0.02-0.770.9-0.780.71
0.490.750.350.570.090.34-0.02-0.610.210.410.150.00.360.230.140.310.530.350.230.410.510.010.380.00.07
-0.140.560.550.27-0.270.970.5-0.76-0.22-0.190.91-0.14-0.40.730.880.020.150.850.23-0.280.17-0.580.87-0.590.82
0.980.02-0.18-0.270.93-0.23-0.79-0.18-0.130.82-0.24-0.010.980.06-0.110.610.14-0.190.41-0.280.510.61-0.170.6-0.18
0.550.31-0.160.030.390.14-0.17-0.4-0.250.290.020.290.460.20.00.510.32-0.020.510.170.510.430.030.43-0.09
0.54-0.43-0.32-0.220.61-0.64-0.570.280.170.3-0.480.310.6-0.01-0.410.51-0.17-0.770.01-0.580.610.43-0.681.0-0.4
-0.040.730.50.23-0.230.910.38-0.75-0.230.040.82-0.14-0.260.570.8-0.050.20.90.380.87-0.170.03-0.68-0.680.78
0.53-0.44-0.33-0.240.61-0.65-0.570.290.160.29-0.490.310.6-0.03-0.420.51-0.18-0.780.0-0.590.60.431.0-0.68-0.4
-0.050.350.560.07-0.090.790.33-0.68-0.19-0.120.890.05-0.320.80.890.16-0.040.710.070.82-0.18-0.09-0.40.78-0.4
Click cells to compare fundamentals

Rockwell Medical Account Relationship Matchups

Rockwell Medical fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets44.3M77.7M48.6M46.6M52.2M37.3M
Other Current Liab4.8M5.1M5.1M7.7M9.9M10.4M
Total Current Liabilities12.4M12.8M21.0M17.7M16.6M9.7M
Total Stockholder Equity20.3M34.2M2.5M14.1M21.3M19.2M
Property Plant And Equipment Net5.6M5.6M10.2M8.6M11.0M11.6M
Net Debt(7.8M)(24.7M)15.6M(5.1M)4.5M4.7M
Retained Earnings(306.5M)(337.4M)(370.1M)(388.8M)(397.2M)(377.3M)
Accounts Payable3.0M4.2M3.7M4.1M4.5M4.1M
Cash11.8M48.7M13.3M21.5M9.0M13.5M
Non Current Assets Total7.4M8.3M13.3M11.3M23.4M24.6M
Non Currrent Assets Other875.9K1.8M2.1M1.8M705K1.1M
Cash And Short Term Investments26.0M58.7M22.4M21.5M10.9M10.4M
Net Receivables4.2M4.2M5.9M6.3M10.9M11.4M
Common Stock Shares Outstanding5.5M6.9M8.5M9.9M23.3M24.5M
Liabilities And Stockholders Equity44.3M77.7M48.6M46.6M52.2M37.3M
Inventory3.6M3.9M4.1M5.8M5.9M3.8M
Other Current Assets3.0M2.7M2.9M1.7M1.1M1.1M
Other Stockholder Equity326.8M371.5M372.6M402.7M418.5M439.4M
Total Liab24.0M43.6M46.0M32.5M30.9M18.1M
Property Plant And Equipment Gross5.6M2.6M17.3M16.2M19.8M20.8M
Total Current Assets36.9M69.5M35.3M35.3M28.8M31.1M
Accumulated Other Comprehensive Income52.0K57K52K163K(1K)(1.1K)
Short Term Debt2.3M1.2M9.8M4.1M2.2M1.8M
Common Stock299.6M6.5K9K1K3K2.9K
Intangible Assets4.0K3.7K3.3K10.8M12.4M13.0M
Common Stock Total Equity273.2M299.6M6.5K9K10.4K9.8K
Other Assets875.9K4.7M2.1M13.8M15.9M16.7M
Short Term Investments14.3M10.0M9.2M11.4M2.0M1.9M
Non Current Liabilities Total11.6M30.8M25.1M14.8M14.2M9.8M
Property Plant Equipment2.9M5.6M10.2M8.6M9.9M10.4M
Current Deferred Revenue2.3M2.3M2.3M1.8M46K43.7K
Net Tangible Assets19.4M33.2M1.6M13.2M11.9M20.7M
Retained Earnings Total Equity(240.3M)(272.4M)(306.5M)(337.4M)(303.7M)(318.8M)
Other Liab9.8M8.0M6M2.6M2.4M2.2M

Currently Active Assets on Macroaxis

When determining whether Rockwell Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rockwell Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rockwell Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rockwell Medical Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rockwell Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Rockwell Stock analysis

When running Rockwell Medical's price analysis, check to measure Rockwell Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rockwell Medical is operating at the current time. Most of Rockwell Medical's value examination focuses on studying past and present price action to predict the probability of Rockwell Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rockwell Medical's price. Additionally, you may evaluate how the addition of Rockwell Medical to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Transaction History
View history of all your transactions and understand their impact on performance
Is Rockwell Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rockwell Medical. If investors know Rockwell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rockwell Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.37)
Revenue Per Share
3.585
Quarterly Revenue Growth
0.144
Return On Assets
(0.08)
Return On Equity
(0.48)
The market value of Rockwell Medical is measured differently than its book value, which is the value of Rockwell that is recorded on the company's balance sheet. Investors also form their own opinion of Rockwell Medical's value that differs from its market value or its book value, called intrinsic value, which is Rockwell Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rockwell Medical's market value can be influenced by many factors that don't directly affect Rockwell Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rockwell Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rockwell Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rockwell Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.